Zonisamide Capsule
NDC Package 29300-430-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Zonisamide capsules is zonisamide is used with other medications to prevent and control seizures (epilepsy). This formulation utilizes a capsule delivery system. Marketed by Unichem Pharmaceuticals (usa), Inc., this product is identified by NDC 29300-430 and is authorized under FDA application ANDA214492.

Identification & Billing

NDC Package Code
29300-430-05
Package Description
500 CAPSULE in 1 BOTTLE
Product Code
11-Digit Billing Format
29300043005
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Zonisamide
Non-Proprietary Name
Zonisamide
Substance Name
Zonisamide
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.

Regulatory & Marketing

Labeler Name
Unichem Pharmaceuticals (usa), Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA214492
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-09-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (29300-430). Click a package code to view its specific billing and regulatory data.

100 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 29300-430-05 identifies a specific commercial package of 500 capsule in 1 bottle of Zonisamide, a human prescription drug labeled by Unichem Pharmaceuticals (usa), Inc.. This capsule is formulated for oral use and contains zonisamide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Unichem Pharmaceuticals (usa), Inc. on July 09, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor. It is unknown how zonisamide works to prevent seizures.

How is this Unichem Pharmaceuticals (usa), Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 29300043005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
29300-430-05
11-Digit CMS (5-4-2)
29300-0430-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.